Eppen_Webinar_June2025
  Editorial
 THE AYUSHSURAKSHA PORTAL   
 Wednesday, June 18, 2025 
 Misleading advertisements and health claims by the Ayurveda, Siddha and Unani drug companies have been a major issue the country has been facing for a long time now. 
  Past Editorial...  
TODAY'S NEWS
17:00  [IST]EMA committee recommends marketing approval of AVT06, Alvotech’s proposed biosimilar to Eylea
16:00  [IST]Navamedic enters agreement to acquire the business of Norwegian-based dne pharma for up to NOK 225 million
15:45  [IST]Novo Nordisk decodes India’s obesity drug market with Wegovy positioned as once-a-week novel weight management medication
15:00  [IST]Harbour BioMed inks strategic collaboration with Otsuka to advance BCMAxCD3 bispecific T-cell engagers
14:15  [IST]Glenmark Pharma launches Tevimbra in India to treat lung and esophageal cancer
14:00  [IST]PTC Therapeutics’ Sephience gets European marketing authorization to treat children and adults living with phenylketonuria
more news >>
TOP NEWS
08:00  [IST]PCI directs institutions to appoint nodal officer & student ambassador to improve coordination
08:00  [IST]Africa-Asia Cold Chain Summit 2026 to deliberate resilient, inclusive & sustainable cold chain systems
08:00  [IST]PLI scheme triggers growth of interdependent value chain in high-precision Medtech: Falgun Jani
08:00  [IST]India schedules oral hearing in anti-dumping probe on Chinese imports of MIPA
08:00  [IST]AKCDA elections to be held on June 29, Philip Cheriyan emerges as key challenger to incumbent president AN Mohan
08:00  [IST]FDI inflow into hospitals & diagnostic centres grew 4 per cent in FY25
more news >>
YESTERDAY'S NEWS
18:00  [IST]Micropep and Corteva announce research collaboration to co-develop next-generation peptide-based biocontrol solutions
17:45  [IST]Novo Nordisk GBS walks the talk on inclusion with Pride March and expanded DEIB agenda
17:20  [IST]Utopia Therapeutics secures $1.5 mn investment from Whale Tank to advance preclinical development of obesity vaccine
16:15  [IST]Zeno Health scales up physical retail with 75 new stores in Maharashtra with Rs. 30 crore investment
14:15  [IST]Lilly’s once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple phase 3 trials
12:30  [IST]Amazon India offers at-home health diagnostics service with sample collection in under 60 minutes & lab results 6 hours across 6 cities
more news >>
INTERVIEW  
All DIs in TN are fully competent to inspect manufacturing units as per Revised Schedule M: MN Sridhar
MN Sridhar, director of the Tamil Nadu Drugs Control Department
Past Interviews...
 
  What's New?  
NPPA notificaiton dated 3rd June, 2025 fixing retail prices of 41 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 133rd Authority meeting dated 29.5.2025
NPPA notification dated 3rd June, 2025 issuing Corrigendum to S.O 4062 (E) dated 8.11.2019, w.r.t M/s Torrent Pharmaceuticals Ltd
NPPA notification dated 6th May, 2025 revising the retail price of 2 applications under Suo Moto framework based on decision of the 132nd Authority meeting dated 29.04.2025
NPPA notification dated 6th May, 2025 revising the ceiling price of one scheduled formulation based on a review order following the decision of the 132nd Authority meeting dated 29.04.2025
NPPA notification dated 6th May, 2025 fixing separate retail price for 3 formulations (new drugs) for M/s Otsuka Pharmaceuticals India Pvt. Ltd. based on decision of the 132nd Authority meeting dated 29.04.2025
 
Opinion Poll
 
 
Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?
 
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
Avians_2025
analytica_Lab_India
CPHISEA25
CPHI_PMEC_China_2025
Pharmatech_Lab_Expo2025
CPHI_Hi_Korea_2025
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram